These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18804219)

  • 1. Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion.
    Lucchiari S; Pagliarani S; Corti S; Mancinelli E; Servida M; Fruguglietti E; Sansone V; Moggio M; Bresolin N; Comi GP; Meola G
    J Neurol Sci; 2008 Dec; 275(1-2):159-63. PubMed ID: 18804219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.
    Cardani R; Mancinelli E; Sansone V; Rotondo G; Meola G
    Eur J Histochem; 2004; 48(4):437-42. PubMed ID: 15718211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
    Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
    Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
    Mankodi A; Teng-Umnuay P; Krym M; Henderson D; Swanson M; Thornton CA
    Ann Neurol; 2003 Dec; 54(6):760-8. PubMed ID: 14681885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual clinical, laboratory, and muscle histopathological findings in a family with myotonic dystrophy type 2.
    Toth C; Dunham C; Suchowersky O; Parboosingh J; Brownell K
    Muscle Nerve; 2007 Feb; 35(2):259-64. PubMed ID: 17068784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2).
    Botta A; Caldarola S; Vallo L; Bonifazi E; Fruci D; Gullotta F; Massa R; Novelli G; Loreni F
    Biochim Biophys Acta; 2006 Mar; 1762(3):329-34. PubMed ID: 16376058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.
    Raheem O; Olufemi SE; Bachinski LL; Vihola A; Sirito M; Holmlund-Hampf J; Haapasalo H; Li YP; Udd B; Krahe R
    Am J Pathol; 2010 Dec; 177(6):3025-36. PubMed ID: 20971734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
    Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies.
    Cardani R; Mancinelli E; Giagnacovo M; Sansone V; Meola G
    Eur J Histochem; 2009; 53(2):107-11. PubMed ID: 19683984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
    Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
    Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygosity for CCTG mutation in myotonic dystrophy type 2.
    Schoser BG; Kress W; Walter MC; Halliger-Keller B; Lochmüller H; Ricker K
    Brain; 2004 Aug; 127(Pt 8):1868-77. PubMed ID: 15231584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).
    Sallinen R; Vihola A; Bachinski LL; Huoponen K; Haapasalo H; Hackman P; Zhang S; Sirito M; Kalimo H; Meola G; Horelli-Kuitunen N; Wessman M; Krahe R; Udd B
    Neuromuscul Disord; 2004 Apr; 14(4):274-83. PubMed ID: 15019706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2.
    Sammons MA; Antons AK; Bendjennat M; Udd B; Krahe R; Link AJ
    PLoS One; 2010 Feb; 5(2):e9301. PubMed ID: 20174632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCUG repeats reduce the rate of global protein synthesis in myotonic dystrophy type 2.
    Schneider-Gold C; Timchenko LT
    Rev Neurosci; 2010; 21(1):19-28. PubMed ID: 20458885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
    Liquori CL; Ricker K; Moseley ML; Jacobsen JF; Kress W; Naylor SL; Day JW; Ranum LP
    Science; 2001 Aug; 293(5531):864-7. PubMed ID: 11486088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploinsuffciency for Znf9 in Znf9+/- mice is associated with multiorgan abnormalities resembling myotonic dystrophy.
    Chen W; Wang Y; Abe Y; Cheney L; Udd B; Li YP
    J Mol Biol; 2007 Apr; 368(1):8-17. PubMed ID: 17335846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2.
    Merlini L; Sabatelli P; Columbaro M; Bonifazi E; Pisani V; Massa R; Novelli G
    Muscle Nerve; 2005 Jun; 31(6):764-7. PubMed ID: 15704146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum.
    Day JW; Ricker K; Jacobsen JF; Rasmussen LJ; Dick KA; Kress W; Schneider C; Koch MC; Beilman GJ; Harrison AR; Dalton JC; Ranum LP
    Neurology; 2003 Feb; 60(4):657-64. PubMed ID: 12601109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.